Dr. Kaltman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8081 Innovation Park Dr
Fairfax, VA 22031Phone+1 571-472-4724Fax+1 571-472-0241
Education & Training
- University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2002 - 2004
- University of Pennsylvania Health SystemResidency, Internal Medicine, 1999 - 2002
- Drexel University College of MedicineClass of 1999
Certifications & Licensure
- DC State Medical License 2010 - 2027
- VA State Medical License 2014 - 2026
- PA State Medical License 2000 - 2022
- MD State Medical License 2007 - 2016
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 4 citationsBody composition and chemotherapy toxicity among women treated for breast cancer: a systematic review.Heather Wopat, Tom Harrod, Rachel F Brem, Rebecca Kaltman, Kendall Anderson
Journal of Cancer Survivorship. 2024-08-01 - Author Correction: Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study.Filipa Lynce, Candace Mainor, Renee N Donahue, Xue Geng, Greg Jones
Nature Communications. 2024-05-10 - 3 citationsAdjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study.Filipa Lynce, Candace Mainor, Renee N Donahue, Xue Geng, Greg Jones
Nature Communications. 2024-03-27
Press Mentions
- 'It's Very Empowering' | New Cancer Clinic Helps Women Assess Risk of Developing Breast CancerOctober 5th, 2022
- Fairfax Is Getting a New Cancer CenterMay 17th, 2022
- Inova Schar Cancer Institute Accepting Participants in Early Detection Study for Pancreatic CancerFebruary 23rd, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: